ATE230746T1 - Optisch aktive pteridinderivate - Google Patents

Optisch aktive pteridinderivate

Info

Publication number
ATE230746T1
ATE230746T1 AT87307803T AT87307803T ATE230746T1 AT E230746 T1 ATE230746 T1 AT E230746T1 AT 87307803 T AT87307803 T AT 87307803T AT 87307803 T AT87307803 T AT 87307803T AT E230746 T1 ATE230746 T1 AT E230746T1
Authority
AT
Austria
Prior art keywords
diastereoisomer
diastereoisomers
optically active
substantially pure
new
Prior art date
Application number
AT87307803T
Other languages
English (en)
Inventor
Hamish Christopher Swan Wood
Lilias Rees
Colin James Suckling
Original Assignee
Univ Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10603634&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE230746(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Strathclyde filed Critical Univ Strathclyde
Application granted granted Critical
Publication of ATE230746T1 publication Critical patent/ATE230746T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Optical Communication System (AREA)
  • Saccharide Compounds (AREA)
  • Cyclones (AREA)
AT87307803T 1986-09-03 1987-09-03 Optisch aktive pteridinderivate ATE230746T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868621268A GB8621268D0 (en) 1986-09-03 1986-09-03 Separation of substances

Publications (1)

Publication Number Publication Date
ATE230746T1 true ATE230746T1 (de) 2003-01-15

Family

ID=10603634

Family Applications (3)

Application Number Title Priority Date Filing Date
AT94102875T ATE231150T1 (de) 1986-09-03 1987-09-03 Optisch aktive verbindungen
AT02018955T ATE295173T1 (de) 1986-09-03 1987-09-03 Pteridinderivat enthaltende pharmazeutische zusammensetzung
AT87307803T ATE230746T1 (de) 1986-09-03 1987-09-03 Optisch aktive pteridinderivate

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT94102875T ATE231150T1 (de) 1986-09-03 1987-09-03 Optisch aktive verbindungen
AT02018955T ATE295173T1 (de) 1986-09-03 1987-09-03 Pteridinderivat enthaltende pharmazeutische zusammensetzung

Country Status (10)

Country Link
US (3) US4959472A (de)
EP (3) EP0266042B1 (de)
JP (3) JP2844532B2 (de)
AT (3) ATE231150T1 (de)
AU (1) AU598024B2 (de)
CA (1) CA1339368C (de)
DE (3) DE3752362T2 (de)
ES (3) ES2189782T3 (de)
GB (1) GB8621268D0 (de)
ZA (1) ZA876562B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223500A (en) * 1977-02-22 1993-06-29 Bioresearch S.P.A. Stable pharmaceutical composition of alkaline or alkaline earth 5-methyl tetrahydrofolate
US5124452A (en) * 1978-07-10 1992-06-23 Bioresearch S.P.A. Process for producing d,1-5-methyltetrahydrofolic acid and its salts
GB8621268D0 (en) * 1986-09-03 1986-10-08 Univ Strathclyde Separation of substances
CH673459A5 (de) * 1987-05-15 1990-03-15 Eprova Ag
DE3821875C1 (de) * 1988-06-29 1990-02-15 Eprova Ag, Forschungsinstitut, Schaffhausen, Ch
JPH0265787A (ja) * 1988-08-30 1990-03-06 Kyowa Hakko Kogyo Co Ltd Ｌ（‐）‐テトラヒドロ葉酸の製造法
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
CH676981A5 (de) * 1988-11-11 1991-03-28 Eprova Ag
IT1229517B (it) * 1989-01-31 1991-09-03 Bioresearch Spa Impiego di acido 5-metiltetraidrofolico, di acido 5 formiltetraidrofolico, e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato adatte ad essere impiegate nella terapia dei disordini depressivi e composizioni farmaceutiche relative.
ATE139799T1 (de) * 1989-12-11 1996-07-15 American Cyanamid Co Verfahren zur herstellung von optisch reinen diastereoisomeren von tetrahydrofolatverbindungen
FR2659330B1 (fr) * 1990-03-09 1994-02-11 Sapec Sa Composes diastereoisomeres derivant de l'acide tetrahydrofolique, procede de preparation et utilisation dans la synthese de diastereomeres 6s et 6r de folates reduits.
CH680731A5 (de) * 1990-04-12 1992-10-30 Sapec Fine Chemicals
US5245053A (en) * 1990-05-04 1993-09-14 American Cyanamid Company Substituted 5-(2-(2-aryl-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxoles
US5153309A (en) * 1990-07-27 1992-10-06 The United States Of America As Represented By The Department Of Health And Human Services Process of making tetrahydropteroylpoly-l-glutamic acid derivatives
CH681303A5 (de) * 1991-01-16 1993-02-26 Eprova Ag
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
DE4136921A1 (de) * 1991-11-11 1993-05-13 Knoll Ag Verfahren zur trennung von 5-methyl-tetrahydrofolsaeure
CH683690A5 (de) * 1991-12-21 1994-04-29 Sapec Fine Chemicals Verfahren zur Herstellung von diastereoisomerenreinen Tetrahydrofolaten.
CH683262A5 (it) * 1992-01-22 1994-02-15 Applied Pharma Res Procedimento per la separazione dei diastereomeri del sale di calcio dell'acido (6(R,S)-N-formiltetraidrofolico).
IT1254635B (it) * 1992-02-20 1995-09-28 Bracco Spa Processo per la separazione degli stereoisomeri dell'acido folinico
US5198547A (en) * 1992-03-16 1993-03-30 South Alabama Medical Science Foundation, Usa Process for N5-formylating tetrahydropteridines
CH684644A5 (de) * 1992-07-13 1994-11-15 Eprova Ag 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
US5698693A (en) * 1992-11-16 1997-12-16 The United States Of America As Represented By The Department Of Health And Human Services Process of separating the diastereomers of (6R,6S) -5,6,7,8-tetrahydrofolic acid derivatives
CH686369A5 (de) * 1994-05-09 1996-03-15 Eprova Ag Stabile kristalline (6S)- und (6R)-Tetrahydrofolseure.
RU2109015C1 (ru) * 1993-07-16 1998-04-20 Эй Си Эс Добфар С.п.А. Способ получения (6s)-изомеров производных фолиевой кислоты
US5498719A (en) * 1994-01-31 1996-03-12 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Diastereoselective process leading to a key intermediate for the preparation of fluorinated reverse transcriptase inhibitors
US5550128A (en) * 1994-09-09 1996-08-27 Nair; Madhavan G. Enantiomers of gamma methylene 10-deaza aminopterin and process for preparing the same
US6162914A (en) * 1998-04-24 2000-12-19 Cerbios-Pharma S.A. Process for the reduction of pterins
JP3330903B2 (ja) * 1999-08-05 2002-10-07 ダイセル化学工業株式会社 フォトレジスト用高分子化合物及びフォトレジスト用樹脂組成物
US20040266732A1 (en) * 2002-09-20 2004-12-30 Jorge Galvez Therapeutic agents, methods, and treatments
WO2005112906A2 (en) * 2004-05-21 2005-12-01 Duke University Method for augmenting the effects of serotonin reuptake inhibitors
JP4956942B2 (ja) * 2004-09-15 2012-06-20 ニプロ株式会社 安定化された注射用水溶液製剤
DE602005026352D1 (de) * 2004-09-15 2011-03-31 Nipro Corp Wässrige, stabile (6S)-Folinsäurelösung zur Injektion
CN101668719B (zh) * 2007-02-07 2013-01-02 日立金属株式会社 低损耗铁氧体及使用其的电子零件
WO2010057515A1 (en) * 2008-11-21 2010-05-27 Synthon B.V. Levocetirizine by menthyl intermediate
ES2703255T3 (es) 2010-10-22 2019-03-07 Univ Duke Formulaciones de liberación lenta de 5-hidroxitriptófano como un complemento para terapias pro-serotoninérgicas
CN102329318B (zh) * 2011-10-20 2013-07-10 浙江圣达药业有限公司 一种高纯度四氢叶酸的制备方法
CN105399747A (zh) * 2015-10-30 2016-03-16 天津药物研究院药业有限责任公司 左旋5，10-亚甲基四氢叶酸的制备方法
CN114516874A (zh) * 2022-03-11 2022-05-20 国药一心制药有限公司 一种甲氨蝶呤新晶型及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2688018A (en) * 1952-06-28 1954-08-31 American Cyanamid Co Method of preparing alkaline earth metal salts of 1-leucovorin
GB1572137A (en) * 1977-02-22 1980-07-23 Bioresearch Sas Del Dr Livio C Stable compositions for therapeutic use based on d,1-5-methyltetrahydrofolic acid and its salts
GB1560372A (en) * 1977-03-21 1980-02-06 Wellcome Found Preparation of calcium folinate
FI812775A7 (fi) * 1980-09-12 1982-03-13 Farmos Oy Menetelmä N-/4-/(2,4-diamino-6- pteridinyyli)-metyyli/- metyyliamino/bentsoyyli/glutamiinihapon ja senjohdannaisten valmistamiseksi.
AU2816384A (en) * 1983-04-11 1984-11-07 University Of South Alabama Regulation of enzymes which utilize tetrahydrobiopterin or tetrahydrofolate cofactors with 6,6-disubstituted- tetrahydropteridines
US4665176A (en) * 1984-10-23 1987-05-12 Mitsui Toatsu Chemicals, Incorporated Process for the preparation of 5,6,7,8-tetrahydrofolic acid
GB8621268D0 (en) * 1986-09-03 1986-10-08 Univ Strathclyde Separation of substances
CH673459A5 (de) * 1987-05-15 1990-03-15 Eprova Ag
CH676981A5 (de) * 1988-11-11 1991-03-28 Eprova Ag

Also Published As

Publication number Publication date
AU7777587A (en) 1988-03-31
DE3752384D1 (de) 2005-06-16
EP0608002A1 (de) 1994-07-27
US6500829B1 (en) 2002-12-31
JPS63115880A (ja) 1988-05-20
GB8621268D0 (en) 1986-10-08
CA1339368C (en) 1997-08-26
EP0266042A2 (de) 1988-05-04
EP1275393A1 (de) 2003-01-15
ZA876562B (en) 1989-06-28
ATE295173T1 (de) 2005-05-15
ES2189782T3 (es) 2003-07-16
DE3752362T2 (de) 2003-11-20
DE3752361T2 (de) 2003-10-30
US6849628B2 (en) 2005-02-01
US20020198212A1 (en) 2002-12-26
ES2241933T3 (es) 2005-11-01
JPH11106342A (ja) 1999-04-20
EP0266042A3 (de) 1989-11-15
DE3752361D1 (de) 2003-02-13
ATE231150T1 (de) 2003-02-15
EP0608002B1 (de) 2003-01-15
EP1275393B1 (de) 2005-05-11
JP2844532B2 (ja) 1999-01-06
DE3752362D1 (de) 2003-02-20
US4959472A (en) 1990-09-25
AU598024B2 (en) 1990-06-14
JP2000136135A (ja) 2000-05-16
DE3752384T2 (de) 2006-01-19
EP0266042B1 (de) 2003-01-08
ES2191669T3 (es) 2003-09-16

Similar Documents

Publication Publication Date Title
DE3752361D1 (de) Optisch aktive Pteridinderivate
CA1258859A (en) CARBOSTYRILE DERIVATIVE, AND ITS PREPARATION
UA27749C2 (uk) Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
ATE49969T1 (de) Verfahren zur herstellung von pteridinderivaten.
KR890003775A (ko) 결정성 세파드록실 모노하이드레이트의 제조방법
CA2031784A1 (en) Process for the preparation of optically pure diastereoisomers of tetrahydrofolate compounds
CS412388A2 (en) Method of 7-piperazino-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxyl acid's derivatives production
CS884386A2 (en) Zpusob vyroby novych soli aryloxypropanolaminu s kyselinou difenyloctovou
TW427991B (en) Production of pharmaceutically acceptable salts of clavulanic acid
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
EP0266690A3 (en) Method for the production of 2,2-disubstituted 3-chlorpropionic acid esters
FI883248A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3,5-dihydroksikarboksyylihappojohdannaisten valmistamiseksi
FI890678A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
ES2003994A6 (es) Procedimiento de preparacion de nuevas 2-cloro-12-(3-dimetilamino-2-metilpropil)-12h-dibenzo(d,g) (i,3,6) dioxazocinas opticamente activas y de sus sales de adicion acidas farmaceuticamente aceptables
ES2001662A6 (es) Metodo para producir acidos 6b -halopenicilanicos asi como sales dse los mismos.
DE3572965D1 (en) Process for the production of optically active quinone derivatives
ES8405781A1 (es) Metodo de obtencion de derivados n-metilcarbamaticos utiles para insecticidas.
GB1387769A (en) Butenoic acid derivatives and a process for the manufacture thereof
KR890003725A (ko) 아민유도체 및 이의 염, 이의 제조방법 및 이를 함유하는 궤양치료제
GR3002699T3 (en) Process for stabilising procaterol
PL262300A1 (en) Process for preparing novel derivatives of l-2,3-diaminopropanic acid of tripeptides structure
JPS56123992A (en) Thiazinoimidazole derivative and its preparation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0266042

Country of ref document: EP

EELA Cancelled due to lapse of time